<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04602962</url>
  </required_header>
  <id_info>
    <org_study_id>KI-KRW-200909-201505</org_study_id>
    <nct_id>NCT04602962</nct_id>
  </id_info>
  <brief_title>Efficacy and Safety of Fertility Treatments and Fertility Preservation</brief_title>
  <official_title>Studies Aiming at Identifying Predictors for Fertility Treatments' Outcomes and to Evaluate the Efficacy and Safety of Fertility Preservation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Karolinska Institutet</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Karolinska University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Karolinska Institutet</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study analyses clinical data prospectively collected for over a decade in several&#xD;
      clinical databases. Electronic medical records are available since 1998.&#xD;
&#xD;
      Since 2011 the subgroup of patients that undergo fertility preservation are invited to&#xD;
      participate in a prospective study aiming at long-term follow-up after fertility preservation&#xD;
      for oncologic and non-oncologic conditions.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this study, the investigators aim at analyze the treatment outcomes of patients with&#xD;
      infertility, their clinical characteristics and biochemical parameters aiming at identifying&#xD;
      predictors for the treatment outcomes.&#xD;
&#xD;
      For the cohort of patients that have undergone fertility preservation at Karolinska&#xD;
      University Hospital, the investigators aim at investigating efficacy and safety of the&#xD;
      procedures.&#xD;
&#xD;
      The data can be expanded by using additional databases such as the Regional Cancer Registry&#xD;
      and other registries.&#xD;
&#xD;
      Analysis of data collected will allow the investigation of efficacy and safety of fertility&#xD;
      preservation, identification of predictors for fertility outcomes,prediction of future&#xD;
      activities and costs of the procedures.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 2009</start_date>
  <completion_date type="Anticipated">December 2030</completion_date>
  <primary_completion_date type="Anticipated">December 2028</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Efficacy and safety of fertility preservation - Long-term follow-up</measure>
    <time_frame>2028</time_frame>
    <description>Correlation between method of fertility preservation and pregnacy rate</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinical outcome of fertility treatments i breast cancer patients</measure>
    <time_frame>5-20 years post diagnosis</time_frame>
    <description>Fertility treatment vs no fertility treatment i breastcancer patients: effect on survival</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical outcome of fertility treatments i breast cancer patients</measure>
    <time_frame>5-7 years post diagnosis</time_frame>
    <description>Fertility treatment vs no fertility treatment i breastcancer patients: effect on disease free survival</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Predictors of effictive fertility treatment</measure>
    <time_frame>patient data collected from time of treatment, pregnancy rate until end of study</time_frame>
    <description>Correlation between clinical variables (age, BMI, oocyte level, administered gonadotropins, infertility) method of fertility preservation and Pregnancy rate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Efficacy and safety of COS using GnRHa for fertility preservation in BC patients</measure>
    <time_frame>Observed outcomes in patients registered between 1995 and 2017. Follow up until end of 2018.</time_frame>
    <description>hCG vs GnRH trigger on effect on number of cryopreserved embryos and oocytes</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">50000</enrollment>
  <condition>Infertility</condition>
  <arm_group>
    <arm_group_label>Fertility preservation performed</arm_group_label>
    <description>subgroup analysis by cause of infertility, clinical characteristics, biochemical markers</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Fertility preservation not performed</arm_group_label>
    <description>subgroup analysis by cause of infertility, clinical characteristics, biochemical markers</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>fertility preservation, several methods</intervention_name>
    <description>fertility preservation using assisted reproductive techniques or not</description>
    <arm_group_label>Fertility preservation performed</arm_group_label>
    <other_name>cryopreservation, surgery</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Cohort collected from the registers of the university hospitals of Sweden, each&#xD;
        representing a health care region, from 1995 and ongoing. FP is included in the tax funded&#xD;
        healthcare system and data is registered all over the country. Date is also compared with&#xD;
        the Swedish tax registry.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  infertile patients and patients who undergo fertility preservation&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Healthy individuals, fertile population&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>56 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dan Grandér, Prof</last_name>
    <role>Study Chair</role>
    <affiliation>Karolinska Institutet</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Dan Grandér, Prof</last_name>
    <email>dan.grander@ki.se</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Susanne Gruber</last_name>
    <email>susanne.gruber@ki.se</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Reproductive Medicine, Karolinska University Hospital</name>
      <address>
        <city>Stockholm</city>
        <zip>141 86</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mats Hellström, RN</last_name>
      <email>mats.hellstrom@karolinska.se</email>
    </contact>
    <investigator>
      <last_name>Birgit Borgström, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Anneli Liljegren, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Anna Marklund, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>May 18, 2015</study_first_submitted>
  <study_first_submitted_qc>October 20, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 26, 2020</study_first_posted>
  <last_update_submitted>October 20, 2020</last_update_submitted>
  <last_update_submitted_qc>October 20, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 26, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Karolinska Institutet</investigator_affiliation>
    <investigator_full_name>Kenny Rodriguez-Wallberg</investigator_full_name>
    <investigator_title>MD, PhD, Associate Professor</investigator_title>
  </responsible_party>
  <keyword>fertility preservation</keyword>
  <keyword>fertility treatment</keyword>
  <keyword>safety</keyword>
  <keyword>efficacy</keyword>
  <keyword>fertility outcomes</keyword>
  <keyword>follow-up</keyword>
  <keyword>cohort</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

